First Eagle Investment Management’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-160,100
Closed -$2.02M 409
2013
Q3
$2.02M Buy
+160,100
New +$2.12M 0.01% 204

First Eagle Investment Management's OPTR Position: Q4 2013 in Review

First Eagle Investment Management sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 160,100 shares — an estimated $2.02M sold.

First Eagle Investment Management first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $2.02M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • First Eagle Investment Management reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • First Eagle Investment Management sold 160,100 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $2.02M.
  • First Eagle Investment Management first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
  • First Eagle Investment Management's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $2.02M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on First Eagle Investment Management's 13F filing for Q4 2013, filed 14 Feb 2014.